| CI | confidence interval |
| DAA | direct-acting antivirals |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| PEG-IFN | pegylated interferon |
| PRISMA | Preferred Reporting Items for Systematic Review and Meta-analysis |
| SVR | sustained virological response |
| CI | confidence interval |
| DAA | direct-acting antivirals |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| PEG-IFN | pegylated interferon |
| PRISMA | Preferred Reporting Items for Systematic Review and Meta-analysis |
| SVR | sustained virological response |